Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Become EABM
Become Reviewer

Editorial [Hot Topic: Appetite Regulation: Future Directions in Obesity Treatment (Guest Editor: Jason C.G. Halford)] promotion: free to download

Volume:6   Issue: 2
Pp: 143-144
Jason C.G. Halford
DOI: 10.2174/1389450053174578

The Role of Apolipoprotein AIV on the Control of Food Intake

Volume:6   Issue: 2
Pp: 145-151
Xiaofa Qin and Patrick Tso
DOI: 10.2174/1389450053174541

Ghrelin and Energy Balance: Focus on Current Controversies

Volume:6   Issue: 2
Pp: 153-169
David E. Cummings, Karen E. Foster-Schubert and Joost Overduin
DOI: 10.2174/1389450053174569

Peptide YY: A Potential Therapy for Obesity

Volume:6   Issue: 2
Pp: 171-179
D. Renshaw and R. L. Batterham
DOI: 10.2174/1389450053174523

Pancreatic Amylin as a Centrally Acting Satiating Hormone

Volume:6   Issue: 2
Pp: 181-189
Thomas A. Lutz
DOI: 10.2174/1389450053174596

Modulation of Eating by Central Catecholamine Systems

Volume:6   Issue: 2
Pp: 191-199
Paul J. Wellman
DOI: 10.2174/1389450053174532

Serotonin (5-HT) Drugs: Effects on Appetite Expression and Use for the Treatment of Obesity

Volume:6   Issue: 2
Pp: 201-213
Jason C.G. Halford, Joanne A. Harrold, Clare L. Lawton and John E. Blundell
DOI: 10.2174/1389450053174550

Cannabinoids and the Regulation of Ingestive Behaviour

Volume:6   Issue: 2
Pp: 215-223
S. P. Vickers and G. A. Kennett
DOI: 10.2174/1389450053174514

The Hypothalamus and Obesity

Volume:6   Issue: 2
Pp: 225-240
Peter J. King
DOI: 10.2174/1389450053174587